The role of statins in endothelial dysfunction in hypertension

Kunal Sarkar, Anjan Sinha, Jawahar L. Mehta

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Hypertension and dyslipidemia frequently coexist, and endothelial dysfunction is associated with the pathophysiology of both atherosclerosis and hypertension. Evidence is convincing for an overlapping role of oxidative stress, renin-angiotensin system activation, and dyslipidemia in the genesis of endothelial dysfunction. RECENT FINDINGS: Ample experimental and human data suggest that common cellular pathways are involved in the pathogenesis of hypertension, increased vascular resistance, and plaque formation. Multiple interventions such as dietary modification, exercise, antioxidants, and antihypertensive drugs improve endothelial dysfunction in hypertension. Statin drugs are a cornerstone of dyslipidemia therapy. Studies have demonstrated that statins correct endothelial function and vascular stiffening and may be useful in reducing blood pressure to target levels. SUMMARY: Statins may be a useful adjunct in the treatment of hypertension in patients with dyslipidemia and possibly those with normal cholesterol levels.

Original languageEnglish (US)
Pages (from-to)316-321
Number of pages6
JournalCurrent Opinion in Cardiology
Volume21
Issue number4
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dyslipidemias
Hypertension
Diet Therapy
Renin-Angiotensin System
Vascular Resistance
Antihypertensive Agents
Blood Vessels
Atherosclerosis
Oxidative Stress
Antioxidants
Cholesterol
Exercise
Blood Pressure
Therapeutics
Pharmaceutical Preparations

Keywords

  • Dyslipidemia
  • Endothelial dysfunction
  • Hypertension
  • Oxidative stress
  • Statins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The role of statins in endothelial dysfunction in hypertension. / Sarkar, Kunal; Sinha, Anjan; Mehta, Jawahar L.

In: Current Opinion in Cardiology, Vol. 21, No. 4, 07.2006, p. 316-321.

Research output: Contribution to journalArticle

Sarkar, Kunal ; Sinha, Anjan ; Mehta, Jawahar L. / The role of statins in endothelial dysfunction in hypertension. In: Current Opinion in Cardiology. 2006 ; Vol. 21, No. 4. pp. 316-321.
@article{59683bbd8a7046f8a06a1c5770aed3bb,
title = "The role of statins in endothelial dysfunction in hypertension",
abstract = "PURPOSE OF REVIEW: Hypertension and dyslipidemia frequently coexist, and endothelial dysfunction is associated with the pathophysiology of both atherosclerosis and hypertension. Evidence is convincing for an overlapping role of oxidative stress, renin-angiotensin system activation, and dyslipidemia in the genesis of endothelial dysfunction. RECENT FINDINGS: Ample experimental and human data suggest that common cellular pathways are involved in the pathogenesis of hypertension, increased vascular resistance, and plaque formation. Multiple interventions such as dietary modification, exercise, antioxidants, and antihypertensive drugs improve endothelial dysfunction in hypertension. Statin drugs are a cornerstone of dyslipidemia therapy. Studies have demonstrated that statins correct endothelial function and vascular stiffening and may be useful in reducing blood pressure to target levels. SUMMARY: Statins may be a useful adjunct in the treatment of hypertension in patients with dyslipidemia and possibly those with normal cholesterol levels.",
keywords = "Dyslipidemia, Endothelial dysfunction, Hypertension, Oxidative stress, Statins",
author = "Kunal Sarkar and Anjan Sinha and Mehta, {Jawahar L.}",
year = "2006",
month = "7",
doi = "10.1097/01.hco.0000231401.87232.71",
language = "English (US)",
volume = "21",
pages = "316--321",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The role of statins in endothelial dysfunction in hypertension

AU - Sarkar, Kunal

AU - Sinha, Anjan

AU - Mehta, Jawahar L.

PY - 2006/7

Y1 - 2006/7

N2 - PURPOSE OF REVIEW: Hypertension and dyslipidemia frequently coexist, and endothelial dysfunction is associated with the pathophysiology of both atherosclerosis and hypertension. Evidence is convincing for an overlapping role of oxidative stress, renin-angiotensin system activation, and dyslipidemia in the genesis of endothelial dysfunction. RECENT FINDINGS: Ample experimental and human data suggest that common cellular pathways are involved in the pathogenesis of hypertension, increased vascular resistance, and plaque formation. Multiple interventions such as dietary modification, exercise, antioxidants, and antihypertensive drugs improve endothelial dysfunction in hypertension. Statin drugs are a cornerstone of dyslipidemia therapy. Studies have demonstrated that statins correct endothelial function and vascular stiffening and may be useful in reducing blood pressure to target levels. SUMMARY: Statins may be a useful adjunct in the treatment of hypertension in patients with dyslipidemia and possibly those with normal cholesterol levels.

AB - PURPOSE OF REVIEW: Hypertension and dyslipidemia frequently coexist, and endothelial dysfunction is associated with the pathophysiology of both atherosclerosis and hypertension. Evidence is convincing for an overlapping role of oxidative stress, renin-angiotensin system activation, and dyslipidemia in the genesis of endothelial dysfunction. RECENT FINDINGS: Ample experimental and human data suggest that common cellular pathways are involved in the pathogenesis of hypertension, increased vascular resistance, and plaque formation. Multiple interventions such as dietary modification, exercise, antioxidants, and antihypertensive drugs improve endothelial dysfunction in hypertension. Statin drugs are a cornerstone of dyslipidemia therapy. Studies have demonstrated that statins correct endothelial function and vascular stiffening and may be useful in reducing blood pressure to target levels. SUMMARY: Statins may be a useful adjunct in the treatment of hypertension in patients with dyslipidemia and possibly those with normal cholesterol levels.

KW - Dyslipidemia

KW - Endothelial dysfunction

KW - Hypertension

KW - Oxidative stress

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33748163009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748163009&partnerID=8YFLogxK

U2 - 10.1097/01.hco.0000231401.87232.71

DO - 10.1097/01.hco.0000231401.87232.71

M3 - Article

VL - 21

SP - 316

EP - 321

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 4

ER -